Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
AIM ImmunoTech Inc. (HEB)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Jun-30-23 | Dec-31-22 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 | Jun-30-21 |
| | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q |
| Revenues | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Cost of goods sold | 0.0% | 35828.6% | 0.0% | 230.0% | 233.3% | 80.0% | 475.8% | 1213.0% |
| Gross profit | 100.0% | -35728.6% | 100.0% | -130.0% | -133.3% | 20.0% | -375.8% | -1113.0% |
| Selling, general and administrative | | | | | | | | |
| Research and development | 7031.0% | 3762.5% | 6533.3% | 8250.0% | 3139.4% | 5846.0% | 6078.8% | 5726.1% |
| General and administrative | 6071.4% | 6258.9% | 24619.0% | 7270.0% | 6278.8% | 5234.0% | 5451.5% | 9326.1% |
| Depreciation | | 16.1% | 42.9% | 33.3% | 30.3% | 350.0% | 481.8% | 708.7% |
| EBITA | -13002.4% | -9628.6% | -30961.9% | -15586.7% | -9493.9% | -10862.0% | -11854.5% | -16100.0% |
| Amortization of intangibles | | 287.5% | 90.5% | 63.3% | 57.6% | 38.0% | 51.5% | 65.2% |
| EBIT | -13002.4% | -9916.1% | -31052.4% | -15650.0% | -9551.5% | -10900.0% | -11906.1% | -16165.2% |
| Pre-tax income | -11688.1% | -7837.5% | -30404.8% | -16170.0% | -11575.8% | -11692.0% | -11593.9% | -25547.8% |
| Income taxes | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -11688.1% | -7837.5% | -30404.8% | -16170.0% | -11575.8% | -11692.0% | -11593.9% | -25547.8% |
|